To evaluate the characteristics of 18F-BMS-986229 as a PET tracer for PD-L1, in vivo PET imaging was performed for the distribution of 18F-BMS-986229 in tumor-bearing mice and the effect of blocking of the tracer binding following BMS-986189 (60 mg/kg) administration. Here, CD274 is linked to neoplasm.